Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
Summary
In a nationwide cohort of 2,025,691 Danish women, combined oral contraceptives doubled the risk of ischemic stroke and MI, while progestin-only pills modestly increased risk. Levonorgestrel-releasing IUDs showed no increased arterial risk. Absolute event rates were low but clinically relevant for risk–benefit counseling.
Key Findings
- Combined oral contraception doubled adjusted rates of ischemic stroke and myocardial infarction versus non-use (aIRR ≈2.0).
- Progestin-only pills increased risk modestly (stroke aIRR 1.6; MI aIRR 1.5).
- Levonorgestrel-releasing intrauterine devices showed no increased risk (stroke aIRR 1.1; MI aIRR 1.1).
Clinical Implications
Use levonorgestrel IUDs when minimizing arterial risk is paramount; discuss small but meaningful arterial risks with combined oral or progestin-only pills, particularly in patients with vascular risk factors.
Why It Matters
This is one of the largest real-world evaluations quantifying arterial thrombotic risks across contemporary contraceptives, isolating a method (levonorgestrel IUD) without excess risk.
Limitations
- Observational design with potential residual confounding (e.g., smoking, blood pressure).
- Generalizability may vary outside Denmark; absolute risks remain low.
Future Directions
Evaluate individualized contraceptive risk calculators integrating vascular risk factors; assess mechanisms and differential progestins’ arterial effects; extend to diverse populations.
Study Information
- Study Type
- Cohort
- Research Domain
- Prevention/Prognosis
- Evidence Level
- II - Large prospective nationwide cohort with adjusted analyses
- Study Design
- OTHER